These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 20188259)
21. Protection of mice and guinea pigs against tuberculosis induced by immunization with a single Mycobacterium tuberculosis recombinant antigen, MTB41. Skeiky YA; Alderson MR; Ovendale PJ; Lobet Y; Dalemans W; Orme IM; Reed SG; Campos-Neto A Vaccine; 2005 Jun; 23(30):3937-45. PubMed ID: 15917115 [TBL] [Abstract][Full Text] [Related]
22. [Immunoprophylaxis of recombinant Mycobacterium vaccae secreted MPT64 of Mycobacterium tuberculosis]. Bai YL; Xue Y; Wang LM; Fan AL; Zhang W; Kang J; He JJ; Xu ZK Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Mar; 25(3):211-4. PubMed ID: 19257983 [TBL] [Abstract][Full Text] [Related]
23. Identification of prostatic acid phosphatase (PAP) specific HLA-DR1-restricted T-cell epitopes. Johnson LE; McNeel DG Prostate; 2012 May; 72(7):730-40. PubMed ID: 22529020 [TBL] [Abstract][Full Text] [Related]
25. MHC class II tetramer guided detection of Mycobacterium tuberculosis-specific CD4+ T cells in peripheral blood from patients with pulmonary tuberculosis. Höhn H; Kortsik C; Zehbe I; Hitzler WE; Kayser K; Freitag K; Neukirch C; Andersen P; Doherty TM; Maeurer M Scand J Immunol; 2007 May; 65(5):467-78. PubMed ID: 17444958 [TBL] [Abstract][Full Text] [Related]
26. Identification and characterization of a WT1 (Wilms Tumor Gene) protein-derived HLA-DRB1*0405-restricted 16-mer helper peptide that promotes the induction and activation of WT1-specific cytotoxic T lymphocytes. Fujiki F; Oka Y; Tsuboi A; Kawakami M; Kawakatsu M; Nakajima H; Elisseeva OA; Harada Y; Ito K; Li Z; Tatsumi N; Sakaguchi N; Fujioka T; Masuda T; Yasukawa M; Udaka K; Kawase I; Oji Y; Sugiyama H J Immunother; 2007 Apr; 30(3):282-93. PubMed ID: 17414319 [TBL] [Abstract][Full Text] [Related]
27. Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide. Bonehill A; Heirman C; Tuyaerts S; Michiels A; Zhang Y; van der Bruggen P; Thielemans K Cancer Res; 2003 Sep; 63(17):5587-94. PubMed ID: 14500399 [TBL] [Abstract][Full Text] [Related]
28. NY-ESO-1 encodes DRB1*0401-restricted epitopes recognized by melanoma-reactive CD4+ T cells. Zarour HM; Storkus WJ; Brusic V; Williams E; Kirkwood JM Cancer Res; 2000 Sep; 60(17):4946-52. PubMed ID: 10987311 [TBL] [Abstract][Full Text] [Related]
29. Vaccination strategy determines the emergence and dominance of CD8+ T-cell epitopes in a FVB/N rat HER-2/neu mouse model of breast cancer. Singh R; Paterson Y Cancer Res; 2006 Aug; 66(15):7748-57. PubMed ID: 16885378 [TBL] [Abstract][Full Text] [Related]
30. Identification of HLA-A24-binding peptides of Mycobacterium tuberculosis derived proteins with beta 2m linked HLA-A24 single chain expressing cells. Ding J; Wang Y; Cheng T; Chen X; Gao B Immunol Invest; 2010 Jan; 39(2):103-13. PubMed ID: 20136618 [TBL] [Abstract][Full Text] [Related]
31. Plasmid interleukin-23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection. Wozniak TM; Ryan AA; Triccas JA; Britton WJ Infect Immun; 2006 Jan; 74(1):557-65. PubMed ID: 16369012 [TBL] [Abstract][Full Text] [Related]
32. Identification of a promiscuous HLA DR-restricted T-cell epitope derived from the inhibitor of apoptosis protein survivin. Piesche M; Hildebrandt Y; Zettl F; Chapuy B; Schmitz M; Wulf G; Trümper L; Schroers R Hum Immunol; 2007 Jul; 68(7):572-6. PubMed ID: 17584578 [TBL] [Abstract][Full Text] [Related]
33. Use of HLA-DR*08032/E7 and HLA-DR*0818/E7 tetramers in tracking of epitope-specific CD4+ T cells in active and convalescent tuberculosis patients compared with control donors. Li Y; Zhu Y; Zhou L; Fang Y; Huang L; Ren L; Peng Y; Li Y; Yang F; Xie D; Tang W; Zhang N; Zhong Q; Lai X Immunobiology; 2011 Aug; 216(8):947-60. PubMed ID: 21281984 [TBL] [Abstract][Full Text] [Related]
34. Hepatitis B virus splice-generated protein induces T-cell responses in HLA-transgenic mice and hepatitis B virus-infected patients. Mancini-Bourgine M; Bayard F; Soussan P; Deng Q; Lone YC; Kremsdorf D; Michel ML J Virol; 2007 May; 81(10):4963-72. PubMed ID: 17360751 [TBL] [Abstract][Full Text] [Related]
35. In silico binding predictions for identification of HLA-DR-promiscuous regions and epitopes of Mycobacterium tuberculosis protein MPT64 (Rv1980c) and their recognition by human Th1 cells. Mustafa AS Med Princ Pract; 2010; 19(5):367-72. PubMed ID: 20639660 [TBL] [Abstract][Full Text] [Related]
36. Identification of minimal CD8+ and CD4+ T cell epitopes in the Plasmodium yoelii hepatocyte erythrocyte protein 17kDa. Dobaño C; Doolan DL Mol Immunol; 2007 Apr; 44(11):3037-48. PubMed ID: 17303242 [TBL] [Abstract][Full Text] [Related]
37. Identification of a ras oncogene peptide that contains both CD4(+) and CD8(+) T cell epitopes in a nested configuration and elicits both T cell subset responses by peptide or DNA immunization. Bristol JA; Orsini C; Lindinger P; Thalhamer J; Abrams SI Cell Immunol; 2000 Nov; 205(2):73-83. PubMed ID: 11104579 [TBL] [Abstract][Full Text] [Related]
38. Improved cellular immune response elicited by a ubiquitin-fused ESAT-6 DNA vaccine against Mycobacterium tuberculosis. Wang QM; Kang L; Wang XH Microbiol Immunol; 2009 Jul; 53(7):384-90. PubMed ID: 19563397 [TBL] [Abstract][Full Text] [Related]